The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-Cyanophenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)propanamide ID: ALA4525698
PubChem CID: 76642967
Max Phase: Preclinical
Molecular Formula: C18H14F3N3O5
Molecular Weight: 409.32
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1
Standard InChI: InChI=1S/C18H14F3N3O5/c1-17(26,10-29-13-5-2-11(9-22)3-6-13)16(25)23-12-4-7-15(24(27)28)14(8-12)18(19,20)21/h2-8,26H,10H2,1H3,(H,23,25)
Standard InChI Key: WSJFKYDVPPVJFF-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 30 0 0 0 0 0 0 0 0999 V2000
26.9054 -13.3021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.4493 -12.0804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4481 -12.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1562 -13.3089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8658 -12.8994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8630 -12.0768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1544 -11.6715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7401 -13.3079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0327 -12.8988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3247 -13.3068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0334 -12.0816 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6173 -12.8977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7391 -13.8840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8989 -13.8840 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.2019 -12.8965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2022 -12.0865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4995 -11.6811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7956 -12.0876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7987 -12.9038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5020 -13.3056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5742 -13.3069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5755 -14.1241 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.2813 -12.8972 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
33.2778 -13.7148 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
32.5713 -11.6642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5682 -10.8470 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.2805 -12.0701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.0873 -11.6811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3787 -11.2740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 2 2 0
3 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 1 0
12 1 1 0
10 13 1 0
10 14 1 0
1 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
5 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
25 26 2 0
25 27 1 0
6 25 1 0
28 29 3 0
18 28 1 0
M CHG 2 25 1 27 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 409.32Molecular Weight (Monoisotopic): 409.0886AlogP: 3.25#Rotatable Bonds: 6Polar Surface Area: 125.49Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.59CX Basic pKa: ┄CX LogP: 3.36CX LogD: 3.36Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -1.41
References 1. Bassetto M, Ferla S, Pertusati F, Kandil S, Westwell AD, Brancale A, McGuigan C.. (2016) Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer., 118 [PMID:27131065 ] [10.1016/j.ejmech.2016.04.052 ]